Compare ASMB & TITN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ASMB | TITN |
|---|---|---|
| Founded | 2005 | 1980 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Other Specialty Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 440.0M | 416.9M |
| IPO Year | 2010 | 2007 |
| Metric | ASMB | TITN |
|---|---|---|
| Price | $29.44 | $19.98 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 5 | 4 |
| Target Price | ★ $44.20 | $20.50 |
| AVG Volume (30 Days) | 70.0K | ★ 177.0K |
| Earning Date | 05-07-2026 | 05-21-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 91.78 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,427,107,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $235.63 | $3.75 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.68 | $13.21 |
| 52 Week High | $39.71 | $21.75 |
| Indicator | ASMB | TITN |
|---|---|---|
| Relative Strength Index (RSI) | 53.25 | 66.54 |
| Support Level | $29.31 | $18.73 |
| Resistance Level | $30.54 | $20.65 |
| Average True Range (ATR) | 1.44 | 0.71 |
| MACD | 0.10 | 0.46 |
| Stochastic Oscillator | 68.18 | 87.47 |
Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.
Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through the following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.